Translation initiation of poliovirus and hepatitis C virus (HCV) RNA occurs by entry of ribosomes to the internal RNA sequence, called the internal ribosomal entry site (IRES). Both IRES bind to the La protein and are thought to require the protein for their translation initiation activity, although they are greatly different in both the primary and predicted secondary structures. To compare the La protein requirement for these IRES, we took advantage of I-RNA from the yeast Saccharomyces cerevisiae, which has been reported to bind to La protein and block poliovirus IRES-mediated translation initiation. In a cell-free translation system prepared from HeLa cells, yeast I-RNA inhibited translation initiation on poliovirus RNA as expected, but did not significantly inhibit translation initiation on HCV RNA. However, the translation initiation directed by either IRES was apparently inhibited by I-RNA in rabbit reticulocyte lysates, in which La protein is limiting. I-RNA-mediated inhibition of HCV IRES-dependent translation in rabbit reticulocyte lysates was reversed by exogenous addition of purified recombinant La protein of smaller amounts than necessary to reverse poliovirus IRES-dependent translation. These results suggest that HCV IRES requires lower concentrations of La protein for its function than does poliovirus IRES. Immunofluorescence studies showed that HCV infection appeared not to affect the subcellular localization of La protein, which exists mainly in the nucleus,
Internal ribosome entry sites (IRES) are RNA structures that allow cap-independent translation. This 1999 study examined the La protein's role in hepatitis C virus (HCV) IRES-mediated translation.
A lower concentration of La protein was sufficient for internal ribosome entry on HCV RNA compared to poliovirus RNA, suggesting differential requirements for host factors in viral translation. This revealed virus-specific mechanisms for hijacking cellular protein synthesis machinery.
Understanding viral translation mechanisms informs development of antiviral strategies. Immune modulators like beta glucan that enhance innate antiviral responses may complement therapies targeting viral replication machinery.
AI-generated summary for accessibility. Always refer to the original paper.
Isoyama T., Kamoshita N., Yasui K., Iwai A., Shiroki K., Toyoda H., Yamada A., Takasaki Y., Nomoto A.. Lower concentration of La protein required for internal ribosome entry on hepatitis C virus RNA than on poliovirus RNA. Journal of General Virology. 1999. DOI: 10.1099/0022-1317-80-9-2319.
For scientific reference only. Not medical advice. Consult a qualified healthcare professional. See our Medical Disclaimer.